Wall St. Watchdog reveals information regarding significant reduction in shares for Barclays PLC’s holdings on the quarter ending September 30th, 2011. The firm is bearish on these stocks:

Cumulus Media Inc. (NASDAQ:CMLS): On 06/30/2011, Barclays PLC reported holding 44,643 shares. On 09/30/2011, Barclays PLC reported holding 2 shares. The net reduction in shares for this position is 44,641 or 100%. About Company: Cumulus Media Inc., a radio broadcasting company, acquires, operates, and develops radio stations in mid-size radio markets in the United States. The Company also provides sales and marketing services under local marketing agreements to various stations in the United States.

Cdc Corporation (CDCAQ.PK): On 06/30/2011, Barclays PLC reported holding 87,982 shares. On 09/30/2011, Barclays PLC reported holding 1 shares. The net reduction in shares for this position is 87,981 or 100%.

Cdc Corp. (NASDAQ:CHINA): On 06/30/2011, Barclays PLC reported holding 87,982 shares. On 09/30/2011, Barclays PLC reported holding 1 shares. The net reduction in shares for this position is 87,981 or 100%. About Company: CDC Corporation develops and markets enterprise software. The Company produces enterprise resource planning, customer relationship management, supply chain management, order management, human resources and payroll management, and business intelligence software. CDC also offers information technology, e-business consulting, web development, and application development services.

Bottomline Technologies Inc. (NASDAQ:EPAY): On 06/30/2011, Barclays PLC reported holding 48,362 shares. On 09/30/2011, Barclays PLC reported holding 2 shares. The net reduction in shares for this position is 48,360 or 100%. About Company: Bottomline Technologies, Inc. provides collaborative payment, invoice and document automation solutions to corporations, financial institutions and banks around the world. The Company’s solutions are used to streamline, automate and manage processes involving payments, invoicing, global cash management, supply chain finance and transactional documents.

Celldex Therapeutics Inc. (NASDAQ:CLDX): On 06/30/2011, Barclays PLC reported holding 743,716 shares. On 09/30/2011, Barclays PLC reported holding 85 shares. The net reduction in shares for this position is 743,631 or 99.99%. About Company: Celldex Therapeutics Inc., a biopharmaceutical company, uses applications of immunology to prevent and treat diseases. The Company’s products treat autoimmune diseases, cardiovascular diseases, cancer, and inflammation, as well as infectious diseases and organ transplant rejection.

(Note: Data regarding Barclays PLC’s stock holdings are sourced from whalewisdom.com. All data are assumed to be accurate.)

Advantage: Check out our interactive stock charts, fundamentals, Twitter stream, and more >>

Improve Your 2011 Financial Health: Join the winning team of stock pickers with Wall St. Cheat Sheet’s acclaimed premium newsletter>>

To contact the reporter on this story: Dave Friedman at staff.writers@wallstcheatsheet.com

To contact the editor responsible for this story: Damien Hoffman at editors@wallstcheatsheet.com

Get Your FREE Special Report: 4 Things You Must Know About the US Economy Now!